Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $2.82 Million - $3.16 Million
14,500 New
14,500 $2.84 Million
Q2 2022

Aug 12, 2022

SELL
$204.13 - $302.4 $1.59 Million - $2.36 Million
-7,800 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $25,551 - $36,211
100 Added 1.3%
7,800 $2.22 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $2.18 Million - $2.78 Million
6,200 Added 413.33%
7,700 $2.9 Million
Q3 2021

Nov 12, 2021

BUY
$372.64 - $458.3 $37,264 - $45,830
100 Added 7.14%
1,500 $619,000
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $411,838 - $520,309
1,400 New
1,400 $518,000
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $3.93 Million - $4.61 Million
-40,000 Closed
0 $0
Q4 2017

Feb 13, 2018

BUY
$100.43 - $118.09 $4.02 Million - $4.72 Million
40,000
40,000 $4.38 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.